Item 7.01-Regulation FD Disclosure
As previously disclosed, on March 3, 2021, Anthem, Inc. (the "Company") will
host its virtual Investor Day conference via live webcast. During the
conference, Company officers intend to reaffirm the full year 2021 guidance
issued in the Company's fourth quarter and full year 2020 earnings release. This
guidance does not reflect the pending acquisition of the Puerto Rico-based
subsidiaries of InnovaCare Health, L.P., including MMM Holdings, LLC and other
affiliated companies, other than earnings per share metrics. The acquisition is
expected to close by the end of the second quarter.
The Company will webcast live the conference on March 3, 2021, beginning at 8:30
a.m. ET, and will make conference materials available on the Company's Investors
page at www.antheminc.com. A replay of the conference will also be available on
the Company's Investors page.
None of the information furnished in Item 7.01 hereto shall be deemed to be
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended. Unless expressly set forth by specific reference in such filings, none
of the information furnished in this report shall be incorporated by reference
in any filing under the Securities Act of 1933, as amended, whether made before
or after the date hereof and regardless of any general incorporation language in
such filings.
FORWARD-LOOKING STATEMENTS
This document contains certain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Forward-looking statements
reflect our views about future events and financial performance and are
generally not historical facts. Words such as "expect," "feel," "believe,"
"will," "may," "should," "anticipate," "intend," "estimate," "project,"
"forecast," "plan" and similar expressions are intended to identify
forward-looking statements. These statements include, but are not limited to:
financial projections and estimates and their underlying assumptions; statements
regarding plans, objectives and expectations with respect to future operations,
products and services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of which are
difficult to predict and generally beyond our control, that could cause actual
results to differ materially from those expressed in, or implied or projected
by, the forward-looking statements. You are cautioned not to place undue
reliance on these forward- looking statements that speak only as of the date
hereof. You are also urged to carefully review and consider the various risks
and other disclosures discussed in our reports filed with the U.S. Securities
and Exchange Commission from time to time, which attempt to advise interested
parties of the factors that affect our business. Except to the extent otherwise
required by federal securities laws, we do not undertake any obligation to
republish revised forward-looking statements to reflect events or circumstances
after the date hereof. These risks and uncertainties include, but are not
limited to: the impact of large scale medical emergencies, such as public health
epidemics and pandemics, including COVID-19, and catastrophes; trends in
healthcare costs and utilization rates; our ability to secure sufficient premium
rates, including regulatory approval for and implementation of such rates; the
impact of federal and state regulation, including ongoing changes in the Patient
Protection and Affordable Care Act and the Health Care and Education
Reconciliation Act of 2010, as amended (collectively, the "ACA") and the
ultimate outcome of legal challenges to the ACA; changes in economic and market
conditions, as well as regulations that may negatively affect our liquidity and
investment portfolios; our ability to contract with providers on cost-effective
and competitive terms; competitive pressures and our ability to adapt to changes
in the industry and develop and implement strategic growth opportunities;
reduced enrollment; unauthorized disclosure of member or employee sensitive or
confidential information, including the impact and outcome of any
investigations, inquiries, claims and litigation related thereto; risks and
uncertainties regarding Medicare and Medicaid programs, including those related
to non-compliance with the complex regulations imposed thereon; our ability to
maintain and achieve improvement in Centers for Medicare and Medicaid Services
Star ratings and other quality scores and funding risks with respect to revenue
received from participation therein; a negative change in our healthcare product
mix; costs and other liabilities associated with litigation, government
investigations, audits or reviews; the ultimate outcome of litigation between
Cigna Corporation and us related to the merger agreement between the parties and
the potential for such litigation to cause us to incur substantial additional
costs, including potential settlement and judgment costs; risks and
uncertainties related to our pharmacy benefit management ("PBM"), business
including non-compliance by any party with the PBM services agreement between us
and CaremarkPCS Health, L.L.C.; medical malpractice or professional liability
claims or other risks related to healthcare and PBM services provided by our
subsidiaries; general risks associated with
--------------------------------------------------------------------------------
mergers, acquisitions, joint ventures and strategic alliances; possible
impairment of the value of our intangible assets if future results do not
adequately support goodwill and other intangible assets; possible restrictions
in the payment of dividends from our subsidiaries and increases in required
minimum levels of capital; our ability to repurchase shares of our common stock
and pay dividends on our common stock due to the adequacy of our cash flow and
earnings and other considerations; the potential negative effect from our
substantial amount of outstanding indebtedness; a downgrade in our financial
strength ratings; the effects of any negative publicity related to the health
benefits industry in general or us in particular; failure to effectively
maintain and modernize our information systems; events that may negatively
affect our licenses with the Blue Cross and Blue Shield Association; the impact
of international laws and regulations; changes in U.S. tax laws; intense
competition to attract and retain employees; and various laws and provisions in
our governing documents that may prevent or discourage takeovers and business
combinations.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses